Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23
always check solution clarity and storage conditions Dose too lowstarting doses are conservative
they rarely require treatment discontinuation
Interventions: Drug: CVN424 75 mg Drug: CVN424 150 mg Drug: Placebo Primary Outcome Measures: Change from Baseline to Week 12 in average daily OFF time on motor diaries for 150 mg CVN424 compared to placebo The assessment of the average daily OFF time, normalized to waking hours will be based on diaries completed at home for three consecutive days during the 7-day period before a scheduled in-person visit
EnReachRx is a high-touch patient support clinical model enabled by pharmacies committed to enhanced clinical care for dispensing GLP-1 prescription medications, integrated throughout the patient journey, and backed by optimized drug spend management
US$ 23.34
US$ 24.36
US$ 21.60
:max_bytes(150000):strip_icc()/Health-GettyImages-2253438005-Exported-0b4e8bc256fc464297ff339a24dd8d60.jpg)
US$ 28.51
